Estudio de fase 2a, aleatorizado, doble ciego, controlado por referencia, que evalúa la inmunogenicidad y la seguridad de OVX836, una vacuna contra la influenza basada en nucleoproteínas https://t.co/2Vb1DknAjY
3,393 followers
3,304 followers
@ThisNThatNews2 Yes, its a protein based vaccine, not mRNA. However we don't yet know if it works in practice, so very over hyped https://t.co/FNIeoQFpVQ
326 followers
Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity ... https://t.co/8eQieO0CJd #GE32
16,957 followers
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine: OVX836 is a recombinant protein-based vaccine targeting the highly.#immunology… https://t.co/E2PNxZW